RetinalGenix Technologies (RTGN) will hire M. Cory Zwerling as its CFO and interim COO, effective January 1, 2026.
Mr. Zwerling brings more than three decades of global experience in healthcare, finance, and operations across pharmaceuticals, medical imaging, biotechnology, and digital health.
